SI-BONE

SI-BONE provides a titanium implant fixation system for the sacroiliac joint using the patented iFuseTM implant with a cannulated delivery system. When compared to the standard SI open fusion procedure, the iFuse implant procedure is less invasive, much quicker and much simpler to achieve fixation of the sacroiliac joint.

SI-BONE headquartered in United States, North America, operates in the Health Care, Hospital, Health Diagnostics sector. The company focuses on Health Care and has secured $21.6B in funding across 96 round(s). With a team of 251-500 employees, SI-BONE is actively contributing to advancements in Health Care. Their latest funding round, Series B - SI-BONE, raised $10.6M. Discover more about their projects, partnerships, and impact on our platform.